SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-020159
Filing Date
2023-03-21
Accepted
2023-03-21 10:21:54
Documents
2
Period of Report
2023-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6288
2 EX-24 DOCUMENT attachment1.htm EX-24 3566
  Complete submission text file 0001209191-23-020159.txt   11285
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE B221 #125 REDMOND WA 98053
Business Address
Pimblett Emily (Reporting) CIK: 0001969365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 23748246